Cancer Cytogenomics Microarray Consortium (CCMC) Company Profile

03:45 EST 16th December 2018 | BioPortfolio

The Cancer Cytogenomics Microarray Consortium (CCMC) was formed in August 2009 by a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists who are interested in applying microarray technologies to cancer diagnosis and cancer research.
The mission of the consortium is to promote communication and collaboration among cancer cytogenomics laboratories. Our goals are to: (1) establish platform-neutral and cancer specific microarray designs for diagnostic purposes, (2) foster collaboration between participating institutions (3), create a public cancer array database and, (4) carry out multi-center cancer translational research. This will ultimately better serve cancer patients and advance the field of cancer genomics.

The CCMC has more than 300 members from over 150 organizations in the U.S., Canada, and abroad.


University of Rochester Medical Center
601 Elmwood Ave, Rochester,


Phone: (585) 275-1077
Fax: (585) 273-3360

News Articles [1879 Associated News Articles listed on BioPortfolio]

CHLA participates in novel cancer consortium announced at the Biden Cancer Summit

(Children's Hospital Los Angeles) Former Vice President Joe Biden and Dr. Jill Biden hosted the national Biden Cancer Summit, on Sept. 21, to highlight the urgent need for creating transformative appr...

Chromosomal Microarray Technologies for Hematologic Neoplasms

What are the advantages and disadvantages of utilizing chromosomal microarray for specific hematologic neoplasms? For which is it most appropriate? American Journal of Clinical Pathology

Immunovia: diagnosing pancreatic cancer from one drop of blood

Mats Grahn, CEO of Immunovia, discusses the future potential for their Antibody Microarray Technology platform for the early detection of pancreatic cancer.

Beat Childhood Cancer Consortium expands into Canada

(Spectrum Health) Helen DeVos Children's Hospital's consortium, known as Beat Childhood Cancer (BCC), announced today that through a partnership with The C17 Council, the organization's first Canadian...

Chinese consortium to acquire German pharma firm AMW

Germany-based drug delivery systems developer AMW has signed an agreement to be acquired by a consortium led by private equity...Read More... The post Chinese consortium to acquire German pharma firm ...

Minnetronix Medical’s division launches Neurapheresis Consortium

Designed to bring together leading researchers and clinicians, the consortium will accelerate the advancement of Neurapheresis Therapy, intended to improve outcomes for multiple, underserved patient p...

Consortium wins $6.6M pediatric medtech grant from FDA

The West Coast Consortium for Technology and Innovation in Pediatrics has received a $6.6 million, five-year Pediatric Device -More- 

Brain cancer: Typical mutation in cancer cells stifles immune response

(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) The exchange of a single amino acid building block in a metabolic enzyme can lead to cancer. In addition, it can impair the imm...

PubMed Articles [6425 Associated PubMed Articles listed on BioPortfolio]

Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium.

Aspirin use is associated with reduced risk of several cancers. A pooled analysis of 12 case-control studies showed a 10% decrease in ovarian cancer risk with regular aspirin use, which was stronger f...

HPV infection and breast cancer. Results of a microarray approach.

Human papilloma virus (HPV) has been implicated in several types of epithelial cancer. The role of HPV in breast carcinogenesis has been a matter of debate fueled by conflicting reports in recent year...

Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression.

Annexin A7 (ANXA7) is a member of the multifunctional calcium or phospholipid-binding annexin gene family. While low levels of ANXA7 are associated with aggressive types of cancer, the clinical impact...

Consortium Outlines 3 Solutions to Maximize the Benefit and Affordability of Targeted Cancer Drugs.

GIS-based method to delimit spheres of influence for a medical consortium: Experience of a pediatric medical consortium, Shanghai.

To improve the utilization efficiency of health care services, the concept of a "regional medical consortium" has attracted more attention during the most recent round of health care reform in China. ...

Clinical Trials [9043 Associated Clinical Trials listed on BioPortfolio]

DNA Microarray Study of Pancreas Cancer

Pancreas cancer and precancerous cysts can be difficult to diagnose. Sometimes biopsies do not show cancer when cancer is actually present. We hypothesize that genetic differences exist in...

Linkage Consortium for End-Stage Renal Disease

The Family Investigation of Nephropathy and Diabetes (FIND)Study is a multi-center consortium. The charge of the consortium is to acquire sets of families with well-characterized diabetic ...

Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique

This is an experimental study of participants who had positive blood culture to compare time to appropriate antibiotic between using Microarray Assay and Mass Spectrometry to bacterial Ide...

Study of Sperm Molecular Factors Implicated in Male Fertility

Sperm analysis following World Health Organization guidelines is unable to explain the molecular causes of male infertility when basic sperm parameters are within a normal range and women ...

Lynne Cohen Consortium Project: Multi-Center Database/Registry

Goals of this registry: 1.1 To collect and store very limited demographic information (age, birthdate, race and ethnicity), limited cancer risk and breast and ovarian disease history, as ...

Companies [1670 Associated Companies listed on BioPortfolio]

Cancer Cytogenomics Microarray Consortium (CCMC)

The Cancer Cytogenomics Microarray Consortium (CCMC) was formed in August 2009 by a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists who are interested in applyin...

WIN Consortium

The WIN Consortium ( is a joint initiative of Institut Gustave Roussy (France) and University of Texas - MD Anderson Cancer Center (USA) which brings togethe...

DNA Microarray (Genome Chip)

Welcome to the DNA Microarray (Genome Chip) Web site! This simple, printer-friendly site has been created and maintained by Leming Shi, Ph.D. You'll find the basics on DNA microarray technology and a ...

Industrial Internet Consortium

The Industrial Internet Consortium® is an open membership organization with over 200 members from 26 countries, formed to accelerate the development, adoption, and wide-spread ...

The Cancer Information Service Research Consortium

More Information about "Cancer Cytogenomics Microarray Consortium (CCMC)" on BioPortfolio

We have published hundreds of Cancer Cytogenomics Microarray Consortium (CCMC) news stories on BioPortfolio along with dozens of Cancer Cytogenomics Microarray Consortium (CCMC) Clinical Trials and PubMed Articles about Cancer Cytogenomics Microarray Consortium (CCMC) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cancer Cytogenomics Microarray Consortium (CCMC) Companies in our database. You can also find out about relevant Cancer Cytogenomics Microarray Consortium (CCMC) Drugs and Medications on this site too.

Quick Search


Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Corporate Database Quicklinks

Searches Linking to this Company Record